Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Emily ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

The first phase of the GLP-1 boom was defined by shortages and brand-name manufacturers sparring with compounding pharmacies. The next phase will be marked by Medicare coverage expansions and new ...

The U.S. FDA has proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list, restricting large-scale compounding of these weight-loss and diabetes drugs. The agency found no ...

The ⁠Food and Drug ⁠Administration proposed excluding the active ingredients in Novo Nordisk ‌and Eli Lilly's blockbuster obesity and diabetes medications from the ⁠list ⁠of drugs that outsourcing ...

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Many people are “microdosing” GLP-1 medications—using ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Ozempic, Zepbound and other glucagonlike peptide 1 (GLP-1) drugs have shown sweeping health benefits—they can control blood sugar, manage body weight and improve heart health. And last year GLP-1 ...

The FDA has proposed removing semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, effectively ending large-scale compounding of these popular GLP-1 drugs. The move follows the ...

Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is being switched off, they want to understand it. Credit...Xia Gordon ...